Novozymes A/S (NVZMF) Stock Price, News & Analysis

Company Overview

Novozymes A/S was a Denmark-based biotechnology company specializing in enzymes and microorganisms for industrial, agricultural, and consumer applications. Its technologies were designed to help customers improve production efficiency, reduce resource use, and develop more sustainable products and processes.

The company developed and marketed enzyme and microbial solutions for industries including food and beverages, household care, agriculture, bioenergy, animal health, and industrial manufacturing. Its products supported applications such as baking, brewing, detergents, textile processing, crop production, animal feed, and the conversion of biomass into renewable fuels and other materials.

Novozymes served customers across global markets through research, production, and commercial operations in multiple regions. The company was established in 2000 through the separation of the enzyme business from Novo Nordisk. In 2024, Novozymes combined with Chr. Hansen Holding A/S to form Novonesis, and Novozymes ceased operating as a standalone company under its former name.

Key Stats

• Today's Range: $68.70 to $68.70
• 50-Day Range: $62.68 to $71.12
• 52-Week Range: $52.10 to $73.07
• Volume: N/A
• Average Volume: 1,382 shs
• Market Capitalization: N/A
• P/E Ratio: 8.57
• Dividend Yield: 2.62%
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 4/20/2016
• Today: 11/03/2026
• Next Earnings (Estimated): 11/05/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Materials
• Industry: Chemicals
• Sub-Industry: Specialty Chemicals
• Current Symbol: OTCMKTS:NVZMF
• CIK: 1131345
• Web: www.novonesis.com
• Phone: (454) 446-0000
• Fax: N/A
• Employees: 11,641
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 8.57
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A